<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib1040">
 <label>207</label>
 <element-citation publication-type="journal" id="ref1035">
  <person-group person-group-type="author">
   <name>
    <surname>Andersson</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Fitts</surname>
    <given-names>E.C.</given-names>
   </name>
   <name>
    <surname>Kirtley</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Ponnusamy</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Peniche</surname>
    <given-names>A.G.</given-names>
   </name>
   <name>
    <surname>Dann</surname>
    <given-names>S.M.</given-names>
   </name>
  </person-group>
  <article-title>New role for FDA-approved drugs in combating antibiotic-resistant bacteria</article-title>
  <source>Antimicrob Agents Chemother</source>
  <volume>60</volume>
  <issue>6</issue>
  <year>2016</year>
  <fpage>3717</fpage>
  <lpage>3729</lpage>
  <pub-id pub-id-type="pmid">27067323</pub-id>
 </element-citation>
</ref>
